A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

NCT02776761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

FED

Sponsor class

Conditions

Hantaan Virus

Interventions

BIOLOGICAL: Hantaan Vaccine:
BIOLOGICAL: Puumala Vaccine
BIOLOGICAL: Hantaan/Puumala Vaccine

Sponsor

U.S. Army Medical Research and Development Command